Detalhe da pesquisa
1.
Breakthrough COVID-19 After Tixagevimab/Cilgavimab Among Patients With Systemic Autoimmune Rheumatic Diseases.
J Rheumatol
; 51(3): 305-312, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37839812
2.
Factors Associated With an Electronic Health Record-Based Definition of Postacute Sequelae of COVID-19 in Patients With Systemic Autoimmune Rheumatic Disease.
J Rheumatol
; 51(5): 529-537, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38428964
3.
Impact of vaccination on postacute sequelae of SARS CoV-2 infection in patients with rheumatic diseases.
Ann Rheum Dis
; 82(4): 565-573, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36442978
4.
Reducing cardiovascular risk with immunomodulators: a randomised active comparator trial among patients with rheumatoid arthritis.
Ann Rheum Dis
; 82(3): 324-330, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36450449
5.
Associations of DMARDs with post-acute sequelae of COVID-19 in patients with systemic autoimmune rheumatic diseases: a prospective study.
Rheumatology (Oxford)
; 2023 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38070152
6.
Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: from the first wave through the initial Omicron wave.
Ann Rheum Dis
; 81(12): 1742-1749, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35944947
7.
Effect of Low-Dose Methotrexate on eGFR and Kidney Adverse Events: A Randomized Clinical Trial.
J Am Soc Nephrol
; 32(12): 3197-3207, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34551998
8.
Adverse Effects of Low-Dose Methotrexate: A Randomized Trial.
Ann Intern Med
; 172(6): 369-380, 2020 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32066146
9.
Cytopenias among patients with rheumatic diseases using methotrexate: a meta-analysis of randomized controlled clinical trials.
Rheumatology (Oxford)
; 59(4): 709-717, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31504937
10.
Immunomodulators and risk for breakthrough COVID-19 after third SARS-CoV-2 mRNA vaccine among patients with rheumatoid arthritis: a cohort study.
Ann Rheum Dis
; 83(5): 680-682, 2024 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38199795
11.
Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases.
Ann Rheum Dis
; 81(2): 289-291, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34489304
12.
Comment on: Cytopenias among patients with rheumatic diseases using methotrexate: a meta-analysis of randomized controlled clinical trials: reply.
Rheumatology (Oxford)
; 59(10): e76, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32705125
13.
A prospective study of dual-energy CT scanning, US and X-ray in acute calcium pyrophosphate crystal arthritis.
Rheumatology (Oxford)
; 59(4): 900-903, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31630175
14.
Effectiveness and tolerability of antifibrotics in rheumatoid arthritis-associated interstitial lung disease.
Semin Arthritis Rheum
; 64: 152312, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38056314
15.
Immunomodulator use, risk factors and management of flares, and mortality for patients with pre-existing rheumatoid arthritis after immune checkpoint inhibitors for cancer.
Semin Arthritis Rheum
; 64: 152335, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38100899
16.
Effectiveness of a fourth dose of COVID-19 mRNA vaccine in patients with systemic autoimmune rheumatic diseases using disease-modifying antirheumatic drugs: an emulated target trial.
Lancet Rheumatol
; 6(1): e21-e30, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38258675
17.
Predictors of low spike antibody response in patients with systemic rheumatic disease after an initial course of COVID-19 vaccination.
Clin Rheumatol
; 42(6): 1695-1700, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36656454
18.
Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines Against COVID-19 Infection Among Patients With Systemic Autoimmune Rheumatic Diseases on Immunomodulatory Medications.
J Rheumatol
; 50(5): 697-703, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36642428
19.
Factors associated with COVID-19 breakthrough infection among vaccinated patients with rheumatic diseases: A cohort study.
Semin Arthritis Rheum
; 58: 152108, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36347211
20.
Risk factors and outcomes for repeat COVID-19 infection among patients with systemic autoimmune rheumatic diseases: A case-control study.
Semin Arthritis Rheum
; 63: 152286, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37913612